Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma.

Jingjng ZouKun ZhangJinde ZhuChaoyong TuJing-Qiang Guo

Published in: The Journal of international medical research (2024)

EphA2 is highly expressed in PAAD and closely related to poor patient prognosis, and is therefore a potential biomarker and target for PAAD diagnosis and treatment.

Keyphrases

case report
binding protein
transcription factor